Uwe Oelmuller
Overview
Explore the profile of Uwe Oelmuller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hardt M, Kaiser F, Voss T, Oelmuller U, Zatloukal K
N Biotechnol
. 2023 Dec;
79:60-70.
PMID: 38145650
After the decline of the COVID-19 pandemic, health systems were challenged by the simultaneous prevalence of different respiratory viruses causing a wide overlap in symptoms. This increased the demand for...
2.
Voss T, Ullius A, Schonborn M, Oelmuller U
PLoS One
. 2021 Jul;
16(7):e0253401.
PMID: 34228726
The field of liquid biopsy has seen extensive growth in recent decades, making it one of the most promising areas in molecular diagnostics. Circulating cell-free DNA (ccfDNA) especially is used...
3.
Grolz D, Hauch S, Schlumpberger M, Guenther K, Voss T, Sprenger-Haussels M, et al.
Curr Pathobiol Rep
. 2019 Jan;
6(4):275-286.
PMID: 30595972
Purpose Of Review: Liquid biopsy analyses based on circulating cell-free nucleic acids, circulating tumor cells or other diseased cells from organs, and exosomes or other microvesicles in blood offer new...
4.
Viertler C, Groelz D, Gundisch S, Kashofer K, Reischauer B, Riegman P, et al.
J Mol Diagn
. 2012 Jul;
14(5):458-66.
PMID: 22749745
For accurate diagnosis, prediction of outcome, and selection of appropriate therapies, the molecular characterization of human diseases requires analysis of a broad spectrum of altered biomolecules, in addition to morphological...
5.
Kap M, Smedts F, Oosterhuis W, Winther R, Christensen N, Reischauer B, et al.
PLoS One
. 2011 Nov;
6(11):e27704.
PMID: 22110732
Within SPIDIA, an EC FP7 project aimed to improve pre analytic procedures, the PAXgene Tissue System (PAXgene), was designed to improve tissue quality for parallel molecular and morphological analysis. Within...
6.
Ullmann S, Hage T, Draheim R, Egerland U, Oelmuller U, Brune K, et al.
J Biomol Screen
. 2004 Mar;
9(2):95-102.
PMID: 15006132
A new system has been developed for RNA-based drug screening, and the feasibility of this approach has been demonstrated by the identification of new immunomodulating compounds. Peripheral blood mononuclear cells...